Clinical trials
Triple Negative Breast Neoplasms trials in Singapore
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 6 |
| Terminated | 6 |
| Active, not recruiting | 3 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 9 |
| Hoffmann-La Roche | 4 |
| Merck Sharp & Dohme LLC | 3 |
| National University Hospital, Singapore | 3 |
| Bayer | 2 |
| Array Biopharma, now a wholly owned subsidiary of Pfizer | 1 |
| Atavistik Bio, Inc | 1 |
| National Cancer Center, Japan | 1 |
| National Cancer Centre, Singapore | 1 |
| Odonate Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 27 |
| Breast Neoplasms | 10 |
| Carcinoma, Non-Small-Cell Lung | 8 |
| Ovarian Neoplasms | 6 |
| Neoplasms | 5 |
| Colorectal Neoplasms | 4 |
| Head and Neck Neoplasms | 4 |
| Carcinoma, Renal Cell | 3 |
| Endometrial Neoplasms | 3 |
| Lung Neoplasms | 3 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.